PHM3 ECONOMIC ANALYSIS OF RECOMBINANT ACTIVATED FACTOR VII IN THE HOME TREATMENT OF MINOR-TO-MODERATE BLEEDS IN HEMOPHILIA PATIENTS WITH INHIBITORS- A U.S. COST-OF-BLEED MODEL
May 1, 2006, 00:00 AM
10.1016/S1098-3015(10)64749-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)64749-3/fulltext
Section Title :
Section Order :
161
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64749-3&doi=10.1016/S1098-3015(10)64749-3